| Literature DB >> 28038742 |
Patrícia I Morgado1, Sónia P Miguel2, Ilídio J Correia3, Ana Aguiar-Ricardo4.
Abstract
During wound healing, an early inflammation can cause an increase of the wound size and the healing process can be considerably belated if a disproportionate inflammatory response occurs. (S)-ibuprofen (IBP), a non-steroidal anti-inflammatory agent, has been used for muscle healing and to treat venous leg ulcers, but its effect in skin wound healing has not been thoroughly studied thus far. Herein, IBP-β-cyclodextrins carriers were designed to customise the release profile of IBP from poly(vinyl alcohol)/chitosan (PVA/CS) dressings in order to promote a faster skin regeneration. The dressings were produced using supercritical carbon dioxide (scCO2)-assisted technique. In vitro IBP release studies showed that β-cyclodextrins allowed a controlled drug release from the hydrogels which is crucial for their application in wound management. Moreover, the in vivo assays revealed that the presence of PVA/CS membranes containing IBP-β-cyclodextrins carriers avoided scab formation and an excessive inflammation, enabling an earlier skin healing.Entities:
Keywords: Composite membranes; Drug delivery systems; Ibuprofen; In vivo assays; Supercritical carbon dioxide; Wound dressings
Mesh:
Substances:
Year: 2016 PMID: 28038742 DOI: 10.1016/j.carbpol.2016.12.029
Source DB: PubMed Journal: Carbohydr Polym ISSN: 0144-8617 Impact factor: 9.381